Wegovy Pill Just Changed: Why Lilly Stock Could Still Win
A new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
Knowing when to modify your financial plan is essential for optimal results. Discover key indicators that signal it's time for adjustments.
22,829 articlesA new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
Salesforce faces a mounting private-equity thesis as cash flow and stock discipline collide with high-profile leaders...
Airbnb embraces AI as a growth engine, with Chesky warning competitors to adapt quickly or risk falling behind, as th...
Major banks reduced price targets on Salesforce ahead of its Q4 earnings, sparking a broader debate about growth pros...
Enterprise Products Partners closed 2025 with record cash flow and a steady ~6% yield, extending a 26-year payout str...
Amazon’s stock is sliding this year as cloud rivals tighten the race and the company leans into a big AI investment. ...
NVIDIA posted a strong quarterly beat, but Wall Street remains hungry for sustained momentum beyond one stellar quart...
Warren Buffett hands the CEO role to Greg Abel, shifting Berkshire Hathaway's guard and fueling a debate about whethe...
Fairway Home Mortgage elevates Holly Mattson to co-president of recruiting to accelerate onboarding of loan producers...
Regulators signal a spring decision to move perpetual Bitcoin futures onto U.S. exchanges. The shift could reshape bi...
Trade Desk stock jumped on reports of a potential partnership with OpenAI, signaling fresh AI-driven upside for ad-te...
Specialized Medicare Advantage plans targeting chronic conditions and low-income subscribers accounted for the majori...